New grant to develop cancer diagnosis tool

Share this on social media:

A project to develop a new kind of scanner that could aid cancer diagnosis and treatment has received a £325k grant to help make the new technology available for general use.

The new scanner from Michelson Diagnostics, uses optical coherence tomography to provide high-resolution images of cancerous tissue below the surface of the skin without any incisions, allowing them to make more accurate decisions about where to perform surgery. The invention of this scanner was covered in by imveurope.com in June this year.

Now however, a new collaboration between Michelson Diagnostics, the University of Cardiff, the Gloucestershire Hospitals NHS Foundation Trust and the UK National Physical Laboratory, plans to make the new device generally available for all hospitals. The new project, called Omicron, has been awarded a £325k grant from the UK’s Technology Strategy Board, to support the development.

Recent News

02 March 2021

Revenue for the company's Industrial Technologies unit was $1.16bn, an increase of 5.9 per cent compared to the prior year, largely because of demand for elevated skin temperature solutions

02 March 2021

Teledyne e2v and Yumain aim to make AI technology more accessible by addressing challenges associated with AI

01 March 2021

Through the acquisition Solid State will be able to further its operations in machine vision, while Active Silicon will have resources to develop its embedded computing and AI capabilities

01 March 2021

Amazon Lookout for Vision is a cloud service, providing a machine learning model that customers can train with their images to spot production defects